5 Stocks Insiders are Buying Now

3. Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Insider Purchase Date: November 13

Clinical stage biopharma company Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) ranks 3rd in our list of the stocks insiders are buying now. Baker Bros. Advisors LP, which has a director status on Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)’s board, bought 107,499 shares of the company earlier this month at $146.99 per share. Over the past one month the stock has gained about 50%.

Earlier this month Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) posted Q3 results. GAAP EPS in the quarter came in at -$5.34 missing estimates by $0.38.